Andrew Briskin

Jul 14, 2023 | diatribe.org | Andrew Briskin |Susannah Chen

Brenzavvy, a type 2 diabetes drug recently approved by the FDA, has just become commercially available at lower cost with no insurance required. Pharmaceutical company TheracosBio has announced that Brenzavvy (bexagliflozin) is now available in the US. The medication is obtainable with a prescription through Cost Plus Drugs, a company that negotiates directly with manufacturers to offer medications at a lower price. Cost Plus is offering a 30-day supply for $47.85 plus shipping and handling.